In a large trial, the approved therapy Winrevair showed confirmed benefits for CpcPH-HFpEF, a type of PH associated with ...

The proportion of people in the U.S. with PAH related to methamphetamine use increased by 93% between 2018 and 2022, a study ...

Winrevair is now covered by several public drug programs in Canada, expanding access for eligible people with PAH.

A naturally occurring signaling molecule called C-type natriuretic peptide, or CNP, was shown to reduce the severity of PAH.

Ten years after his pulmonary hypertension diagnosis, columnist Mike Naple reflects on what he's learned about strength.

As a lifelong patient, columnist Anna Jeter has seen many inaccuracies on TV medical dramas. "The Pitt" is a big improvement, ...

Measuring microRNAs in blood may help identify group 2 PH (pulmonary hypertension), with levels linked to disease severity in a small study.

Pulmonary hypertension is a chronic and progressive disease characterized by high blood pressure in the pulmonary arteries, the blood vessels of the lungs. There are many potential causes of the ...

The rare and severe lung disease called pulmonary hypertension (PH) affects the pulmonary arteries, causing high blood pressure. The pulmonary arteries transport the blood from the right heart ...

Higher blood levels of immunoglobulin E (IgE), an immune molecule typically linked to allergies, are associated with worse right heart function in people with pulmonary arterial hypertension (PAH), ...

Treatment with mosliciguat, an inhaled medication given once-daily for pulmonary hypertension (PH), can safely reduce the resistance against blood flow in blood vessels of the lungs, according to a ...